These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 20032425

  • 1. Immunological similarities between cancer and chronic fatigue syndrome: the common link to fatigue?
    Meeus M, Mistiaen W, Lambrecht L, Nijs J.
    Anticancer Res; 2009 Nov; 29(11):4717-26. PubMed ID: 20032425
    [Abstract] [Full Text] [Related]

  • 2. Intracellular immune dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: state of the art and therapeutic implications.
    Nijs J, Frémont M.
    Expert Opin Ther Targets; 2008 Mar; 12(3):281-9. PubMed ID: 18269338
    [Abstract] [Full Text] [Related]

  • 3. [Chronic fatigue immune dysfunction syndrome].
    Uchida A.
    Nihon Rinsho; 1992 Nov; 50(11):2625-9. PubMed ID: 1287238
    [Abstract] [Full Text] [Related]

  • 4. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression.
    Maes M, Mihaylova I, Leunis JC.
    Neuro Endocrinol Lett; 2007 Dec; 28(6):861-7. PubMed ID: 18063934
    [Abstract] [Full Text] [Related]

  • 5. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I, DeRuyter M, Rummens JL, Bosmans E, Maes M.
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [Abstract] [Full Text] [Related]

  • 6. Impairments of the 2-5A synthetase/RNase L pathway in chronic fatigue syndrome.
    Nijs J, De Meirleir K.
    In Vivo; 2005 Aug; 19(6):1013-21. PubMed ID: 16277015
    [Abstract] [Full Text] [Related]

  • 7. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?
    Van Houdenhove B, Van Den Eede F, Luyten P.
    Med Hypotheses; 2009 Jun; 72(6):701-5. PubMed ID: 19237251
    [Abstract] [Full Text] [Related]

  • 8. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
    Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, Komaroff AL, Ritz J.
    J Immunol; 1987 Nov 15; 139(10):3306-13. PubMed ID: 2824604
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents.
    ter Wolbeek M, van Doornen LJ, Kavelaars A, van de Putte EM, Schedlowski M, Heijnen CJ.
    Brain Behav Immun; 2007 Nov 15; 21(8):1063-74. PubMed ID: 17544255
    [Abstract] [Full Text] [Related]

  • 10. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
    Raison CL, Lin JM, Reeves WC.
    Brain Behav Immun; 2009 Mar 15; 23(3):327-37. PubMed ID: 19111923
    [Abstract] [Full Text] [Related]

  • 11. Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome.
    Maes M, Mihaylova I, Kubera M, Bosmans E.
    Neuro Endocrinol Lett; 2007 Aug 15; 28(4):463-9. PubMed ID: 17693978
    [Abstract] [Full Text] [Related]

  • 12. Aetiology and pathogenesis of chronic fatigue syndrome: a review.
    Mihrshahi R, Beirman R.
    N Z Med J; 2005 Dec 16; 118(1227):U1780. PubMed ID: 16372029
    [Abstract] [Full Text] [Related]

  • 13. Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis.
    Bassi N, Amital D, Amital H, Doria A, Shoenfeld Y.
    Isr Med Assoc J; 2008 Jan 16; 10(1):79-82. PubMed ID: 18300582
    [Abstract] [Full Text] [Related]

  • 14. Unravelling intracellular immune dysfunctions in chronic fatigue syndrome: interactions between protein kinase R activity, RNase L cleavage and elastase activity, and their clinical relevance.
    Meeus M, Nijs J, McGregor N, Meeusen R, De Schutter G, Truijen S, Frémont M, Van Hoof E, De Meirleir K.
    In Vivo; 2008 Jan 16; 22(1):115-21. PubMed ID: 18396793
    [Abstract] [Full Text] [Related]

  • 15. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome.
    Buchwald D, Wener MH, Pearlman T, Kith P.
    J Rheumatol; 1997 Feb 16; 24(2):372-6. PubMed ID: 9034999
    [Abstract] [Full Text] [Related]

  • 16. Pain in patients with chronic fatigue syndrome: does nitric oxide trigger central sensitisation?
    Nijs J, Van de Velde B, De Meirleir K.
    Med Hypotheses; 2005 Feb 16; 64(3):558-62. PubMed ID: 15617866
    [Abstract] [Full Text] [Related]

  • 17. Is chronic fatigue syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry?
    Staines DR.
    Med Hypotheses; 2004 Feb 16; 62(5):646-52. PubMed ID: 15082083
    [Abstract] [Full Text] [Related]

  • 18. Exercise capacity and immune function in male and female patients with chronic fatigue syndrome (CFS).
    Snell CR, Vanness JM, Strayer DR, Stevens SR.
    In Vivo; 2005 Feb 16; 19(2):387-90. PubMed ID: 15796202
    [Abstract] [Full Text] [Related]

  • 19. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?
    Ortega-Hernandez OD, Shoenfeld Y.
    Ann N Y Acad Sci; 2009 Sep 16; 1173():600-9. PubMed ID: 19758205
    [Abstract] [Full Text] [Related]

  • 20. Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS.
    Maes M, Mihaylova I, De Ruyter M.
    J Affect Disord; 2006 Feb 16; 90(2-3):141-7. PubMed ID: 16338007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.